Log in to save to my catalogue

Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIME...

Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIME...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_867a62a89e52445e93ea1a90def82e6d

Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies

About this item

Full title

Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2019-11, Vol.18 (1), p.151-151, Article 151

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The pandemic of cardiovascular disease (CVD) and type 2 diabetes (T2D) requires the identification of new predictor biomarkers. Biomarkers potentially modifiable with lifestyle changes deserve a special interest. Our aims were to analyze: (a) The associations of lysine, 2-aminoadipic acid (2-AAA) or pipecolic acid with the risk of T2D or CVD in the...

Alternative Titles

Full title

Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_867a62a89e52445e93ea1a90def82e6d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_867a62a89e52445e93ea1a90def82e6d

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-019-0958-2

How to access this item